Gilead leukemia study gets complete response
Australia | News | By BioSpectrum Bureau | 0 Comment | 16 May, 2013
Singapore: Gilead Sciences' phase II study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, ...Read more
Fund freeze by Australia govt worries biotech
Australia | News | By BioSpectrum Bureau | 0 Comment | 20 Sep, 2012
Singapore: AusBiotech calls on the Federal Government to provide some certainty to the innovation sector as support pro...Read more
Projects under Indo-Australia Biotechnology Fund
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 18 May, 2012
...Read more
FDA accepts resubmission of Moxduo NDA by QRxPharma
Australia | News | By BioSpectrum Bureau | 0 Comment | 15 Mar, 2013
Singapore: The US Food and Drug Administration (FDA) has set August 26, 2013, as the date for action on QRxPharma's res...Read more
Mr Schwarz: We track samples at subzero degrees
Australia | Influencers | By BioSpectrum Bureau | 0 Comment | 10 Dec, 2012
Melbourne-based bluechiip is a tracking technology company that was listed on the Australia Stock Exchange in June 2011....Read more
ASX biotech stock surge 54 percent in 2013
Australia | News | By BioSpectrum Bureau | 0 Comment | 07 Jan, 2014
Singapore: Analysis from leading healthcare fund manager BioScience Managers has highlighted the outstanding year for bi...Read more
Aus Govt, Apotex sue Sanofi for extending patent
Australia | News | By BioSpectrum Bureau | 0 Comment | 22 Apr, 2013
Singapore: The Australian government has joined hands with generics manufacturer Apotex in suing Sanofi Aventis seeking ...Read more
What functional roles do CROs play in APAC?
Australia | Analysis | By BioSpectrum Bureau | 3 Comment | 18 Sep, 2013
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...Read more
Phosphagenics to begin oxymorphone patch trial
Australia | News | By BioSpectrum Bureau | 0 Comment | 17 Jan, 2013
Singapore: Melbourne-based drug delivery technology company, Phosphagenics, is going to launch phase I study of a transd...Read more
Massive cancer vaccination starts in Aus schools
Australia | News | By BioSpectrum Bureau | 0 Comment | 22 Feb, 2013
Singapore: Australian schoolboys have begun receiving the first-of-three vaccinations to protect them against cancers a...Read more
Patrys gets approval for myeloma trials in Australia
Australia | News | By BioSpectrum Bureau | 0 Comment | 05 Nov, 2012
Singapore: Patrys has received approval to commence its planned phase I/IIa multiple myeloma trial with lead anti-canc...Read more
AtCor revenue up by 41 percent in FY 2013
Australia | Company results | By BioSpectrum Bureau | 4 Comment | 02 Sep, 2013
Singapore: AtCor Medical, the developer and marketer of the SphygmoCor system that measures central aortic blood pressur...Read more
Patrys cancer drug gives hope to patients
Australia | News | By BioSpectrum Bureau | 0 Comment | 08 May, 2013
Singapore: Patrys, a clinical stage biopharmaceutical company, has confirmed anti-cancer properties of PAT-SM6 and has d...Read more
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 22 Jun, 2015
Singapore: The bioscience industry in the major markets of Asia-Pacific region, excluding Japan and comprising Australia...Read more
BSA-CMR Survey: New CRO players emerge in APAC
Australia | Analysis | By BioSpectrum Bureau | 3 Comment | 18 Sep, 2013
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...Read more
ImmusanT starts trials of celiac disease vaccine, Nexvax2
Australia | News | By BioSpectrum Bureau | 0 Comment | 05 Sep, 2012
Singapore: ImmusanT initiated clinical trials in New Zealand, Australia and the US to evaluate Nexvax2, the first thera...Read more
Queensland marks 15% less HIV cases in 2013
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 06 Sep, 2013
Singapore: Ministerial Advisory Committee on HIV/AIDS (MAC) in Australia has achieved 15 percent reduction in HIV notifi...Read more
Alchemia gets US patent for oncology platform technology
Australia | News | By BioSpectrum Bureau | 0 Comment | 06 Mar, 2013
Singapore: Brisbane-based drug discovery and development company Alchemia has been granted a key US patent critical to ...Read more